These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9759255)

  • 1. [Vaccine trials in ambulatory pediatrics].
    Langue J
    Arch Pediatr; 1998; 5 Suppl 2():182s-183s; discussion 183s-187s. PubMed ID: 9759255
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity assays and surrogate markers to predict vaccine efficacy.
    Käyhty H
    Dev Biol Stand; 1998; 95():175-80. PubMed ID: 9855429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory pediatrics. Introduction.
    Korsch BM
    Adv Pediatr; 1973; 20():9-13. PubMed ID: 4773793
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms underlying adverse reactions to vaccines.
    Siegrist CA
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S46-50. PubMed ID: 17559869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccinations. Immunological and microbiological bases, indications, contra-indications, complications, efficacy (excluding mandatory dates and characteristic of vaccinations)].
    Beytout J
    Rev Prat; 1994 Nov; 44(18):2487-96. PubMed ID: 7855513
    [No Abstract]   [Full Text] [Related]  

  • 6. A phased approach to clinical testing: criteria for progressing from Phase I to Phase II to Phase III studies.
    André FE; Foulkes MA
    Dev Biol Stand; 1998; 95():57-60. PubMed ID: 9855414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.
    Olivier C; Belohradsky BH; Stojanov S; Bonnet E; Petersen G; Liese JG
    Vaccine; 2008 Jun; 26(25):3142-52. PubMed ID: 18502545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring and safety assessment in Phase I to III clinical trials.
    Fescharek R; Nicolay U; Arras-Reiter C
    Dev Biol Stand; 1998; 95():203-9. PubMed ID: 9855433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response to different vaccines].
    Bégué P
    Arch Pediatr; 1998; 5 Suppl 2():182s-187s. PubMed ID: 9841084
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vaccines' adverse events: questions and answers brought by InfoVac].
    Cohen R; Siegrist CA
    Arch Pediatr; 2006 Jun; 13(6):650-2. PubMed ID: 16690277
    [No Abstract]   [Full Text] [Related]  

  • 11. [Palliative management in pediatrics: responding to needs at the child appropriate level].
    Stahl S
    Pflege Z; 2006 Jul; 59(7):432-5. PubMed ID: 16883743
    [No Abstract]   [Full Text] [Related]  

  • 12. Ambulatory care of the hemophiliac.
    Tetrick AP
    J Assoc Care Child Hosp; 1978; 7(2):19-27. PubMed ID: 10318423
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving warfarin therapy in children: anticoagulation clinics are just the beginning.
    Massicotte P
    Thromb Res; 2004; 114(1):1-3. PubMed ID: 15262477
    [No Abstract]   [Full Text] [Related]  

  • 14. Rotavirus vaccines, an update.
    Can Commun Dis Rep; 2003 May; 29(9):82-3. PubMed ID: 12739276
    [No Abstract]   [Full Text] [Related]  

  • 15. The nature and consequences of intra- and inter-vaccine interference.
    Vidor E
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S62-6. PubMed ID: 17560593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The quest for an HIV vaccine].
    Girard MP
    Bull Acad Natl Med; 2005 May; 189(5):831-44; discussion 844. PubMed ID: 16433455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The delivery of ambulatory diabetes care: structures, processes, and outcomes of ambulatory diabetes care.
    Pihoker C; Forsander G; Wolfsdorf J; Klingensmith GJ
    Pediatr Diabetes; 2008 Dec; 9(6):609-20. PubMed ID: 19067893
    [No Abstract]   [Full Text] [Related]  

  • 18. [Difficulties with conducting clinical trials in France].
    Zannad F; Plétan Y
    Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A framework for assessing immunological correlates of protection in vaccine trials.
    Qin L; Gilbert PB; Corey L; McElrath MJ; Self SG
    J Infect Dis; 2007 Nov; 196(9):1304-12. PubMed ID: 17922394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acellular pertussis vaccines: new preparation. Better tolerated but less active?
    Prescrire Int; 2000 Feb; 9(45):204-7. PubMed ID: 11503797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.